Therefore, although our results indicate significant differences only in the PYCR1 isoform, it would seem appropriate to refrain from definite conclusions dismissing the role of PYCR2 and PYCR3 in gliomas until the wider context of the multi-layered metabolic network involved is better understood. The gene discussed is PYCR2; the disease is central nervous system cancer.